ATE173637T1 - Diagnostisches mittel zur bestimmung von pankreasinsuffiziens - Google Patents

Diagnostisches mittel zur bestimmung von pankreasinsuffiziens

Info

Publication number
ATE173637T1
ATE173637T1 AT91912962T AT91912962T ATE173637T1 AT E173637 T1 ATE173637 T1 AT E173637T1 AT 91912962 T AT91912962 T AT 91912962T AT 91912962 T AT91912962 T AT 91912962T AT E173637 T1 ATE173637 T1 AT E173637T1
Authority
AT
Austria
Prior art keywords
fluorescein
mannitol
insufficiency
pancreasic
determining
Prior art date
Application number
AT91912962T
Other languages
English (en)
Inventor
Stephen R Jollifee
Lawrence T Weaver
Original Assignee
Unicliffe Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909015851A external-priority patent/GB9015851D0/en
Priority claimed from GB919114042A external-priority patent/GB9114042D0/en
Application filed by Unicliffe Ltd filed Critical Unicliffe Ltd
Application granted granted Critical
Publication of ATE173637T1 publication Critical patent/ATE173637T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT91912962T 1990-07-19 1991-07-18 Diagnostisches mittel zur bestimmung von pankreasinsuffiziens ATE173637T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909015851A GB9015851D0 (en) 1990-07-19 1990-07-19 Diagnostic composition for assessment of pancreatic insufficiency
GB919114042A GB9114042D0 (en) 1991-06-27 1991-06-27 Paediatric diagnostic composition

Publications (1)

Publication Number Publication Date
ATE173637T1 true ATE173637T1 (de) 1998-12-15

Family

ID=26297348

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91912962T ATE173637T1 (de) 1990-07-19 1991-07-18 Diagnostisches mittel zur bestimmung von pankreasinsuffiziens

Country Status (6)

Country Link
EP (1) EP0539432B1 (de)
AT (1) ATE173637T1 (de)
AU (1) AU8107991A (de)
DE (1) DE69130531T2 (de)
GB (1) GB2246707B (de)
WO (1) WO1992001478A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1316320A4 (de) 2000-09-07 2005-12-07 Tokyo Gas Co Ltd Mittel zur diagnose extrapankreatischer sekretion
DE10253664B4 (de) * 2002-11-18 2005-02-03 Gauchel, Gisela, Dr. Diagnoseverfahren
EP1901781A2 (de) * 2005-06-21 2008-03-26 Mallinckrodt, Inc. Optische bildkontrastmittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3806592A (en) * 1970-12-18 1974-04-23 Rohm & Haas Method for evaluating bile sufficiency
DE2314270A1 (de) * 1973-03-22 1974-09-26 Boehringer Mannheim Gmbh Hochwirksame zubereitungsform von fluoresceinestern und verfahren zur herstellung derselben
NO884565L (no) * 1987-10-15 1989-04-17 Univ Moskovsk Preparat for kontrastdannelse ved diagnose av ondartet neoplasma.
SE467861B (sv) * 1987-12-18 1992-09-28 Kabi Pharmacia Ab Emulsion foer parenteral administrering

Also Published As

Publication number Publication date
EP0539432A1 (de) 1993-05-05
GB2246707A (en) 1992-02-12
GB9115524D0 (en) 1991-09-04
DE69130531D1 (de) 1999-01-07
AU8107991A (en) 1992-02-18
EP0539432B1 (de) 1998-11-25
DE69130531T2 (de) 1999-04-22
WO1992001478A1 (en) 1992-02-06
GB2246707B (en) 1995-01-25

Similar Documents

Publication Publication Date Title
Sripa et al. Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis
TR199701713T1 (xx) Hepatit C a��lar�.
DE3681286D1 (de) Behandlung von emulsionen.
DE59705683D1 (de) IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG
FI841788A0 (fi) Enteralt kontrastmedel foer protonkaernspintomografi.
KR840003028A (ko) 종양치료제의 오일상 조성물의 제조방법
ES2054658T3 (es) Metodo para la preparacion de una emulsion fisiologicamente aceptable.
ATE118177T1 (de) Emulsion.
ES544483A0 (es) Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros.
FR2590704B1 (fr) Methode de diagnostic automatique de l'etat de fonctionnement d'un appareil
ES2102513T3 (es) Procedimiento para separar una impureza de ester de un eter.
Michael et al. Stage specific secreted and somatic antigens of Trichinella spiralis
ATE173637T1 (de) Diagnostisches mittel zur bestimmung von pankreasinsuffiziens
FI882738L (fi) Röntgenvarjoaineena käytettävä jodipitoinen emulsio
CA2207505A1 (en) Neurological drug screens
EP0886142A4 (de) Methode zur bestimmung von anti-gadii antikörpern und methode zur krebsdiagnose
FI905005A7 (fi) Tyydytettyjä C20-24-rasvahappoja sisältäviä triglyseridejä, jotka ovatkäyttökelpoisia alentamaan veren kolesterolipitoisuutta
FI885806A0 (fi) Polypeptider av stvl-iii-typ, diagnostiska system och analysfoerfarande.
ATE76557T1 (de) Oel-in-wasser-emulsion.
PL277263A1 (en) Method of obtaining affino-enzymatic compounds for visual indication of cholesterol on patient's skin
Endoh et al. Effect of purified heat-labile toxin of Bordetella bronchiseptica on the peripheral blood vessels in guinea pigs or suckling mice
SE8605389L (sv) Sett att diagnostisera kikhosta och testsats for utforande av settet
DE2640707A1 (de) Gewinnung von im darm resorbierbaren protein- und peptidloesungen
DE19540669A1 (de) Interferon-Zusammensetzung
FI881447L (fi) Diagnos av pankreassjukdom.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties